| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5712b4838bdb16ebbc41121239e165b9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-913 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555 |
| filingDate |
1974-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1976-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42b17305bfb4f9f1c9542165ed043f1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eb789f317505a212d4a480415d6e2eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176a871abb61e0a97b5d6c609595dc8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92d3470507489e6819960bdb4b97f473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d33f457eaf4cfc5bb7f92a3a87b26084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc5fecd4925e36f9478789c6fece9b1f |
| publicationDate |
1976-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3966707-A |
| titleOfInvention |
Process for preparing double stranded RNA |
| abstract |
Virus particles capable of stimulating the production of interferon are isolated from fungal cells of the mould Aspergillus foetidus or Aspergillus niger or from the nutrient medium in which or on which Aspergillus foetidus or Aspergillus niger mould has been grown. Double-stranded RNA material can be isolated from the virus particles extracted from Aspergillus foetidus or Aspergillus niger and said RNA material is capable of stimulating production of interferon. Pharmaceutical compositions comprising said particles or said RNA material in combination with pharmaceutically acceptable carriers and excipients are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4213970-A |
| priorityDate |
1971-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |